Anemia Trials in Detroit, United States
Conditions / Anemia / Detroit, United States
Anemia is a medical condition with active clinical research programs worldwide.
41 total trials for this combination
Showing top 10 of 41 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02648347 | Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease | COMPLETED | PHASE3 |
| NCT02048813 | Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ACTIVE_NOT_RECRUITING | — |
| NCT00843882 | Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia | ACTIVE_NOT_RECRUITING | — |
| NCT02048813 | Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ACTIVE_NOT_RECRUITING | — |
| NCT00843882 | Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia | ACTIVE_NOT_RECRUITING | — |
| NCT00358215 | RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial | COMPLETED | PHASE3 |
| NCT02680574 | Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) | COMPLETED | PHASE3 |
| NCT02048813 | Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ACTIVE_NOT_RECRUITING | — |
| NCT00843882 | Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia | ACTIVE_NOT_RECRUITING | — |
| NCT00004917 | Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer | COMPLETED | PHASE3 |